NASDAQ:CLSN
Delisted

Celsion Stock Predictions

etoro logo Buy CLSN
*Your capital is at risk
$1.56
+0.0600 (+4.00%)
At Close: Jan 27, 2023
Currently predicting for Mon, 8 Jun 2026

CLSN Prediction Chart

CLSN Predictions History

Latest community submissions for CLSN.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jan 14, 2021 $0.94 +3.89% $0.90 X 96.11% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Jul 27, 2020 $3.62 +212.07% Unrealistic Excluded from avg $1.16 X 0.00% 0
JS JS Pro
Jul 27, 2020 $1.29 +11.21% $1.16 X 88.79% 0
Sòñù Pàùl Sòñù Pàùl @SC3B2C3B1C3B9PC3A0C3B9l.169569
Jul 27, 2020 $1.50 +29.31% $1.16 X 70.69% 0
JS JS Pro
Jul 20, 2020 $1.20 +11.11% $1.08 X 88.89% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Jul 20, 2020 $1.14 +5.56% $1.08 X 94.44% 0
Ronnier Pascual Ronnier Pascual @RonnierPascual.168663
Jul 20, 2020 $1.09 +0.93% $1.08 X 99.07% 2
May 3, 2019 $2.19 +0.46% $2.18 X 99.54% 4
Apr 29, 2019 $2.07 -9.01% $2.28 X 90.99% 0
JS JS Pro
Jul 5, 2018 $3.13 -1.88% $3.19 X 98.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLSN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELSION CORPORATION
Celsion
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE